What is it about?
The COVID-19 is primarily a disease of the respiratory system, but SARS-CoV-2 also penetrates other organs (multisystem disease), causing various symptoms, including olfactory and gustatory dysfunction. The frequency of anosmia and ageusia in patients with COVID-19 is common but according to different papaers varies widely, from 10 to 65%, being the primary symptom in about 12% of patients. Most of the analyzed subjects reported olfactory recovery. However, anosmia and ageusia can last several months or even longer. We do not yet know what long-term consequences these disorders may have on the central nervous system and mental health in general.
Featured Image
Why is it important?
We do not yet know what long-term consequences anosmia and ageusia may have on the central nervous system and mental health in general, but we have to keep in mind these facts in future.
Perspectives
It is possible that anosmia and ageusia may have some role in increase frequency of neurodegenerative disease in the future.
Osman Sinanovic
University of Tuzla
Read the Original
This page is a summary of: Anosmia and Ageusia in Sars-Cov-2 Infection, Medical Research Archives, January 2023, Knowledge Enterprise Journals,
DOI: 10.18103/mra.v11i8.4182.
You can read the full text:
Contributors
The following have contributed to this page
